Boston Scientific has announced that it is taking a new approach to evaluate the performance of its Vessix renal denervation system—it is initiating a study with a novel design to isolate the effects of the therapy in patients with high blood pressure. The REDUCE-HTN: REINFORCE randomised, sham-controlled, multicentre study is designed to isolate and demonstrate the effects of the Vessix renal denervation system by minimising variability and factors that may have affected results in SYMPLICITY HTN-3.
Silk Road Medical has announced the first US commercial procedure using the Enroute transcarotid neuroprotection system was successfully performed at Mills-Peninsula Medical Center in Burlingame, USA by vascular surgeon John E Rosenman.
Many nursing home residents who underwent lower extremity revascularization died, did not walk or had functional decline following the procedure, which is commonly used to treat leg pain caused by peripheral arterial disease, wounds that will not heal or worsening gangrene, according to an article published online by JAMA Internal Medicine.
In experienced hands, non-target embolization is rare, a study presented at the European Congress of Radiology (ECR, 4–8 March, Vienna, Austria) concluded.
A study presented at the Society of Interventional Radiology’s (SIR’s) 2015 annual scientific meeting reveals that a new angiographic imaging platform (AlluraClarity, Philips Healthcare) maintains similar procedure time as a current C-arm imaging platform (Allura, Philips), yet with substantially reduced radiation exposure for uterine artery embolization procedures.
Terumo has announced that on 16 March 2015 it received CE mark for LifePearl, a new drug-eluting microsphere for chemoembolization and HydroPearl, a new microsphere for more predictable bland embolization.
Medtronic has announced the initiation of the SPYRAL HTN global clinical trial programme, a phased clinical programme studying renal denervation in uncontrolled hypertension. This announcement follows investigational device exemption approval by the US Food and Drug Administration (FDA).
A rapid overview of three of these treatments: ablation, chemoembolization and selective interval radiation therapy, should help clarify the challenges and difficulties of determining tumour response in interventional oncology, write Maxime Ronot and Valérie Vilgrain.
In the past five years we have treated more than 400 patients for uterine fibroids, bone metastasis and osteoid osteoma in routine practice with significant clinical results and negligible adverse events, but therapeutic ultrasound still has some technological hurdles that need to be overcome, writes Alessandro Napoli.
A study published in the British Journal of Surgery has provided international validation of the St George’s Vascular Institute (SGVI) risk score, which has been developed to predict the risk of complications in patients undergoing endovascular aortic aneurysm repair (EVAR).
Giovanni Mauri, Milan, Italy, reported the results of the study on the treatment of benign biliary strictures with a novel bioresorbable biliary stent, EllaDV (Ellacs) at the European Congress of Radiology (ECR, 4–8 March, Vienna, Austria).
A study from France presented at the European Congress of Radiology (ECR, 4–8 March, Vienna, Austria) has found that percutaneous thermal ablation is safe and effective for local control of metastatic breast cancer.
TomTec has announced FDA 510(k) clearance for its TomTec-Arena software solution. TomTec-Arena is a suite of clinical applications to review, analyse and quantify medical image data in multiple dimensions (2D and 3D/4D) and multiple modalities such as ultrasound, X-ray angiography, magnetic resonance and nuclear medicine imaging.
3D printing could become a powerful tool in customising interventional radiology treatments to individual patient needs, with clinicians having the ability to construct devices to a specific size and shape, according to a study being presented at the Society of Interventional Radiology’s Annual Scientific Meeting (28 February–5 March, Atlanta, USA). Researchers and engineers collaborated to print catheters, stents and filaments that were bioactive, giving these devices the ability to deliver antibiotics and chemotherapeutic medications to a targeted area in cell cultures.
Patients suffering from chronic plantar fasciitis now have a new treatment option against this debilitating foot ailment, according to research presented at the Society of Interventional Radiology’s annual scientific meeting.
Cookies Sociales
Son esos botones que permiten compartir el contenido del sitio web en sus redes sociales (Facebook, Twitter y Linkedin, previo tu consentimiento y login) a través de sistemas totalmente gestionados por dichas redes sociales, así como los recursos (pej. videos) y material que se encuentra en nuestra web, y que de igual manera se presta y gestiona completamente por un tercero.
Si no acepta estas cookies, no podrá compartir nuestro contenido a través de los botones, y en su caso, no podrás visualizar el contenido de terceros que hayamos incrustado en el sitio.
No las utilizamos